Company · Glasgow
Neuropathology 2027 Limited
Neuropathology 2027 Limited is an active UK company (number SC757605), incorporated 2023, with 3 current directors including Karl Joachim Frontzek and Silvia Marino. Source: Companies House, updated 25th October 2026.
Other education n.e.c.
The people who lead this organisation are listed below. Create a free account to save it, get alerts and check how you are connected.
Official record Companies House · updated 25th October 2026 · Sources · Free, no card or password
Network
The large node is Neuropathology 2027 Limited. Red nodes are organisations, white nodes are people. Dashed links are historical or inferred. Click any node to explore.
Who leads it
Previous officers 2
- Dr Daniel Gerhardus Du Plessis 2023-2025 View profile
- Dr Tammaryn Claire Lashley 2023-2025 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- What it does
- Other education n.e.c.
- Incorporated
- 03/02/2023
- Registered office
- Glasgow
Ownership
Owned by (4) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Silvia Marino
significant influence · notified 2026-03-04 - Tammaryn Lashley ceased 2025-11-13
significant influence, significant influence (firm) · notified 2023-02-23 - Tammaryn Lashley ceased 2025-11-17
25-50% shares, 25-50% voting · notified 2025-11-13 - FM Events Consultancy Limited ceased 2023-02-06
75-100% shares, 75-100% voting, appoints directors · notified 2023-02-03
Group
No holder of more than 50% of the shares or voting rights, or of the right to appoint or remove a majority of the directors, is recorded on the PSC register for Neuropathology 2027 Limited.
Ownership paths are calculated from the active Companies House persons-with-significant-control filings that show a majority (more than 50% of shares or voting rights, or the right to appoint or remove a majority of the directors). Each step shows the filed nature of control and dates. Holdings of 25-50% are significant influence or control, not majority control, and are not used to build a group.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
3 directors on the board
- Dr Colin Smith Director · appointed 2023
- Karl Joachim Frontzek Director · appointed 2025
- Silvia Marino Director · appointed 2025
First-time vs portfolio directors
First-time (2)
- Dr Colin Smith Director · appointed 2023
- Karl Joachim Frontzek Director · appointed 2025
Portfolio (1)
- Silvia Marino Director · appointed 2025
Also govern a charity
Left in the last 12 months
- Dr Daniel Gerhardus Du Plessis Director · appointed 2023 · resigned 2025
- Dr Tammaryn Claire Lashley Director · appointed 2023 · resigned 2025
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- SC757605
- Status
- Active
- Type
- Private Limited Company
- Accounts next due
- 30/11/2026
- Edition
- Register edition compiled 25th October 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data